Cinven Theramex Acquisition: £2.2 Billion Deal for Platform Worth Four Times Its 2018 Price
· techtimes.com · popularity 18/100 · 0 similar stories today · Wealth, Power & Society (Society, Rights & Work)
Read the original at techtimes.com →
Summary
Private equity firm Cinven has agreed to acquire Theramex, the women's health pharmaceutical company, from Carlyle and PAI Partners for approximately 2.2 billion pounds -- the third private equity ownership change in eight years for a platform originally carved out of Teva for $703 million in 2018, as European women's health M&A hits a 20-year high.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 11.